董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mark E. Andrews, III | 男 | chairman of the board | 68 | 20.25万美元 | 未持股 | 2019-01-25 |
| Henry C. Beinstein | 男 | Director | 75 | 3.34万美元 | 35.50 | 2019-01-25 |
| Phillip Frost | 男 | Director | 82 | 2.79万美元 | 5422.13 | 2019-01-25 |
| Richard M. Krasno | 男 | Director | 77 | 3.34万美元 | 18.00 | 2019-01-25 |
| Richard J. Lampen | 男 | President and Chief Executive Officer,Director | 65 | 20.00万美元 | 668.85 | 2019-01-25 |
| Mark Zeitchick | 男 | Director | 53 | 3.04万美元 | 25.50 | 2019-01-25 |
| John F. Beaudette | 男 | Director | 62 | 3.29万美元 | 24.02 | 2019-01-25 |
| Steven D. Rubin | 男 | Director | 58 | 3.79万美元 | 25.60 | 2019-01-25 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Richard J. Lampen | 男 | President and Chief Executive Officer,Director | 65 | 20.00万美元 | 668.85 | 2019-01-25 |
| John S. Glover | 男 | Executive Vice President and Chief Operating Officer | 64 | 69.47万美元 | 237.79 | 2019-01-25 |
| T. Kelley Spillane | 男 | Senior Vice President - Global Sales | 56 | 58.23万美元 | 109.21 | 2019-01-25 |
| Alfred J. Small | 男 | Senior Vice President, Chief Financial Officer, Treasurer & Secretary | 50 | 54.73万美元 | 106.60 | 2019-01-25 |
| Alejandra Pena | 女 | Senior Vice President - Marketing | 51 | 42.80万美元 | 48.61 | 2019-01-25 |
董事简历
中英对照 | 中文 | 英文- Mark E. Andrews, III
-
Mark E. Andrews, III是我司董事会主席，他于1998年创立了我司前身公司Great Spirits Company LLC，并从其成立开始担任其董事会主席、总裁兼首席执行官直到2003年12月截止。Andrews先生从2003年12月开始担任我司董事会主席，从2003年12月到2005年11月，担任我司总裁。从2003年12月到2008年11月，Andrews先生担任我司首席执行官。创立我司前身公司前，Andrews先生于1980年创立了American Exploration Company，该公司致力于石油与天然气的勘探与生产。他于1983年负责该公司的上市，并担任其董事会主席兼首席执行官直到其于1997年10月与Louis Dreyfus Natural Gas Corp.合并。他还担任纽约市的纽约长老会医院（New York Presbyterian Hospital）的终身理事。Andrews先生相关的工作经验、任职资格、品质与工作技能包括，金融素养与专业知识、行业经验、管理经验，以及他担任上市公司的董事和高管而获得的知识与经验。
Mark E. Andrews, III, our chairman of the board, founded our predecessor company, Great Spirits Company LLC, in 1998 and served as its chairman of the board, president and chief executive officer from its inception until December 2003. Mr. Andrews has served as our chairman of the board since December 2003 and served as our president from December 2003 until November 2005. Mr. Andrews served as our chief executive officer from December 2003 until November 2008. Prior to founding our predecessor, Mr. Andrews founded American Exploration Company, a company engaged in the exploration and production of oil and natural gas, in 1980. He oversaw that company becoming publicly traded in 1983 and served as its chairman and chief executive officer until its merger with Louis Dreyfus Natural Gas Corp. in October 1997. He also serves as a life trustee of The New York Presbyterian Hospital in New York City. - Mark E. Andrews, III是我司董事会主席，他于1998年创立了我司前身公司Great Spirits Company LLC，并从其成立开始担任其董事会主席、总裁兼首席执行官直到2003年12月截止。Andrews先生从2003年12月开始担任我司董事会主席，从2003年12月到2005年11月，担任我司总裁。从2003年12月到2008年11月，Andrews先生担任我司首席执行官。创立我司前身公司前，Andrews先生于1980年创立了American Exploration Company，该公司致力于石油与天然气的勘探与生产。他于1983年负责该公司的上市，并担任其董事会主席兼首席执行官直到其于1997年10月与Louis Dreyfus Natural Gas Corp.合并。他还担任纽约市的纽约长老会医院（New York Presbyterian Hospital）的终身理事。Andrews先生相关的工作经验、任职资格、品质与工作技能包括，金融素养与专业知识、行业经验、管理经验，以及他担任上市公司的董事和高管而获得的知识与经验。
- Mark E. Andrews, III, our chairman of the board, founded our predecessor company, Great Spirits Company LLC, in 1998 and served as its chairman of the board, president and chief executive officer from its inception until December 2003. Mr. Andrews has served as our chairman of the board since December 2003 and served as our president from December 2003 until November 2005. Mr. Andrews served as our chief executive officer from December 2003 until November 2008. Prior to founding our predecessor, Mr. Andrews founded American Exploration Company, a company engaged in the exploration and production of oil and natural gas, in 1980. He oversaw that company becoming publicly traded in 1983 and served as its chairman and chief executive officer until its merger with Louis Dreyfus Natural Gas Corp. in October 1997. He also serves as a life trustee of The New York Presbyterian Hospital in New York City.
- Henry C. Beinstein
-
Henry C. Beinstein，2004年3月以来一直是Ladenburg Thalmann Financial Services Inc.公司董事。他自2005年1月以来担任Gagnon Securities LLC的合伙人，该公司是经纪自营商，是美国金融业监管局（FINRA）成员公司，并自2002年8月以来一直是短期资本经营者和该公司注册代表。他于2002年8月退休，当时担任驻纽约的律师事务所Schulte Roth & Zabel LLP的执行董事，他于1997年8月就担任该职位。在此之前，1995年11月初，他担任纽约律师事务所Milbank, Tweed, Hadley & McCloy LLP的董事总经理。从1985年4月到1995年10月，他担任纽约律师事务所Proskauer Rose LLP的执行董事。Beinstein先生是在纽约和新泽西的注册会计师，加入Proskauer之前，是Coopers & Lybrand的合伙和全国财政和行政主管。他还担任Ladenburg Thalmann Financial Services Inc. 公司和Castle Brands Inc.公司的董事。他自1968年被纽约州授权为注册会计师。他目前的相关经验、资格、特性和技能，来自于他在Coopers & Lybrand公司、Proskauer Rose LLP公司、Milbank公司、Tweed公司、Hadley & McCloy LLP公司以及Schulte Roth & Zabel LLP公司获得的金融知识和专业知识、管理经验等，以及他作为其他上市公司的董事而获得的知识和经验等。
Henry C. Beinstein,has been a director of the Company since March 2004. Since January 2005, Mr. Beinstein has been a partner of Gagnon Securities LLC, a broker-dealer and FINRA member firm, and has been a money manager and registered representative at such firm since August 2002. He retired in August 2002 as the Executive Director of Schulte Roth & Zabel LLP, a New York-based law firm, a position he had held since August 1997. Before that, Mr. Beinstein had served as the Managing Director of Milbank, Tweed, Hadley & McCloy LLP, a New York-based law firm, commencing November 1995. Mr. Beinstein was the Executive Director of Proskauer Rose LLP, a New York-based law firm, from April 1985 through October 1995. Mr. Beinstein is a certified public accountant in New York and prior to joining Proskauer was a partner and National Director of Finance and Administration at Coopers & Lybrand. He also holds the designation of Chartered Global Management Accountant from the American Institute of Certified Public Accountants. Mr. Beinstein also served as a director of LTS and Castle Brands Inc., prior to the sale of these companies in February 2020 and October 2019, respectively. Mr. Beinstein has been licensed as a Certified Public Accountant in the state of New York since 1968. - Henry C. Beinstein，2004年3月以来一直是Ladenburg Thalmann Financial Services Inc.公司董事。他自2005年1月以来担任Gagnon Securities LLC的合伙人，该公司是经纪自营商，是美国金融业监管局（FINRA）成员公司，并自2002年8月以来一直是短期资本经营者和该公司注册代表。他于2002年8月退休，当时担任驻纽约的律师事务所Schulte Roth & Zabel LLP的执行董事，他于1997年8月就担任该职位。在此之前，1995年11月初，他担任纽约律师事务所Milbank, Tweed, Hadley & McCloy LLP的董事总经理。从1985年4月到1995年10月，他担任纽约律师事务所Proskauer Rose LLP的执行董事。Beinstein先生是在纽约和新泽西的注册会计师，加入Proskauer之前，是Coopers & Lybrand的合伙和全国财政和行政主管。他还担任Ladenburg Thalmann Financial Services Inc. 公司和Castle Brands Inc.公司的董事。他自1968年被纽约州授权为注册会计师。他目前的相关经验、资格、特性和技能，来自于他在Coopers & Lybrand公司、Proskauer Rose LLP公司、Milbank公司、Tweed公司、Hadley & McCloy LLP公司以及Schulte Roth & Zabel LLP公司获得的金融知识和专业知识、管理经验等，以及他作为其他上市公司的董事而获得的知识和经验等。
- Henry C. Beinstein,has been a director of the Company since March 2004. Since January 2005, Mr. Beinstein has been a partner of Gagnon Securities LLC, a broker-dealer and FINRA member firm, and has been a money manager and registered representative at such firm since August 2002. He retired in August 2002 as the Executive Director of Schulte Roth & Zabel LLP, a New York-based law firm, a position he had held since August 1997. Before that, Mr. Beinstein had served as the Managing Director of Milbank, Tweed, Hadley & McCloy LLP, a New York-based law firm, commencing November 1995. Mr. Beinstein was the Executive Director of Proskauer Rose LLP, a New York-based law firm, from April 1985 through October 1995. Mr. Beinstein is a certified public accountant in New York and prior to joining Proskauer was a partner and National Director of Finance and Administration at Coopers & Lybrand. He also holds the designation of Chartered Global Management Accountant from the American Institute of Certified Public Accountants. Mr. Beinstein also served as a director of LTS and Castle Brands Inc., prior to the sale of these companies in February 2020 and October 2019, respectively. Mr. Beinstein has been licensed as a Certified Public Accountant in the state of New York since 1968.
- Phillip Frost
-
Phillip Frost，医学博士， 2007年3月以来担任Ladenburg Thalmann Financial Services Inc.公司的CEO和董事会主席。2010年3月，他被任命为Teva Pharmaceutical Industries, Limited, or Teva NYSE：TEVA董事会主席，2006年1月Teva 被IVAX Corporation收购时，他曾担任董事会副主席。他于1987年曾任IVAX公司董事会主席兼首席执行官。1972年至1986年，他担任位于迈阿密的美国西奈山医学中心皮肤科（the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami）主任。他于1972年是Key Pharmaceuticals, Inc.董事会主席，直至该公司在1986年被Schering Plough Corporation收购。他于2006年7月被任命为Ladenburg Thalmann Financial Services Inc. （NYSE MKT：LTS）董事会主席，LTS是一家投资银行、资产管理、证券经纪公司，通过其主要的运营子公司Ladenburg Thalmann & Co . Inc 。 而提供服务。2001年到2002年、以及2004年至今，他是Ladenburg Thalmann董事会成员。他担任迈阿密大学（the University of Miami）理事会、俄罗斯the Skolkovo-Scientific Advisory Council顾问委会、中国上海先进免疫化学研究所（the Shanghai Institute for Advanced Immunochemical Studies in China）、佛罗里达受托委员会（The Florida Council）100名成员之一，并是the Miami Jewish Home for the Aged和西奈山医疗中心（the Mount Sinai Medical Center）理事会成员。他也是高档品牌开发和营销商Castle Brands （NYSE MKT：ROX）董事、开发抗病毒治疗人类疾病的生物科技公司Biozone Pharmaceuticals Inc. （OTCBB： BZNE）、发展阶段医疗设备公司TransEnterix,Inc 。（OTCBB：TRXC）（TRXC开创性的使用灵活的仪器和机器人提高微创手术）等公司的董事。他之前于2013年8月担任Continucare Corporation公司、SafeStitch Medical Inc.公司（并入TransEnterix, Inc.公司之前）、PROLOR Biotech, Inc.公司（被Cocrystal Pharma, Inc.收购之前）的董事，于2012年12月担任美国证交所（现在的纽约证交所MKT）主管人员和联席副主席，并直至2012年11月担任the Scripps Research Institute理事会成员。他已成功建立一些制药公司，并监管大量医药产品的发展和商业化。
Phillip Frost,has been the Chief Executive Officer of the Company and Chairman of the Board since March 2007. Dr. Frost serves as a director for Cocrystal Pharma, Inc. (NASDAQ GM:COCP), a biotechnology company developing new treatments for viral diseases. He also currently serves on the board of Grove Bank & Trust and Morgan Solar. He has been a member of the Board of Trustees of the University of Miami since 1983 and was Chairman from 2001 to 2004. He is on the Advisory Board of the Shanghai Institute for Advanced Immunochemical Studies in China, is a member of The Florida Council of 100 and is a trustee of the Miami Jewish Home for the Aged and serves on the Executive Committee of the Board of Mount Sinai Medical Center. He serves as Chairman of Temple Emanu-El, Governor of Tel Aviv University and is a member of the Executive Committee of The Phillip and Patricia Frost Museum of Science. Dr. Frost served as a director of Ladenburg Thalmann Financial Services Inc. from 2004 to 2006 and as Chairman from July 2006 until September 2018. Dr. Frost previously served as a director for Castle Brands (NYSE American:ROX). Dr. Frost had served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation ("IVAX") from 1987 until its acquisition by Teva in January 2006. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc. from 1972 until its acquisition by Schering Plough Corporation in 1986. Dr. Frost was a Governor of the American Stock Exchange from 1992 to 2008 and Co-Vice Chairman from 2001 until its merger with the New York Stock Exchange. - Phillip Frost，医学博士， 2007年3月以来担任Ladenburg Thalmann Financial Services Inc.公司的CEO和董事会主席。2010年3月，他被任命为Teva Pharmaceutical Industries, Limited, or Teva NYSE：TEVA董事会主席，2006年1月Teva 被IVAX Corporation收购时，他曾担任董事会副主席。他于1987年曾任IVAX公司董事会主席兼首席执行官。1972年至1986年，他担任位于迈阿密的美国西奈山医学中心皮肤科（the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami）主任。他于1972年是Key Pharmaceuticals, Inc.董事会主席，直至该公司在1986年被Schering Plough Corporation收购。他于2006年7月被任命为Ladenburg Thalmann Financial Services Inc. （NYSE MKT：LTS）董事会主席，LTS是一家投资银行、资产管理、证券经纪公司，通过其主要的运营子公司Ladenburg Thalmann & Co . Inc 。 而提供服务。2001年到2002年、以及2004年至今，他是Ladenburg Thalmann董事会成员。他担任迈阿密大学（the University of Miami）理事会、俄罗斯the Skolkovo-Scientific Advisory Council顾问委会、中国上海先进免疫化学研究所（the Shanghai Institute for Advanced Immunochemical Studies in China）、佛罗里达受托委员会（The Florida Council）100名成员之一，并是the Miami Jewish Home for the Aged和西奈山医疗中心（the Mount Sinai Medical Center）理事会成员。他也是高档品牌开发和营销商Castle Brands （NYSE MKT：ROX）董事、开发抗病毒治疗人类疾病的生物科技公司Biozone Pharmaceuticals Inc. （OTCBB： BZNE）、发展阶段医疗设备公司TransEnterix,Inc 。（OTCBB：TRXC）（TRXC开创性的使用灵活的仪器和机器人提高微创手术）等公司的董事。他之前于2013年8月担任Continucare Corporation公司、SafeStitch Medical Inc.公司（并入TransEnterix, Inc.公司之前）、PROLOR Biotech, Inc.公司（被Cocrystal Pharma, Inc.收购之前）的董事，于2012年12月担任美国证交所（现在的纽约证交所MKT）主管人员和联席副主席，并直至2012年11月担任the Scripps Research Institute理事会成员。他已成功建立一些制药公司，并监管大量医药产品的发展和商业化。
- Phillip Frost,has been the Chief Executive Officer of the Company and Chairman of the Board since March 2007. Dr. Frost serves as a director for Cocrystal Pharma, Inc. (NASDAQ GM:COCP), a biotechnology company developing new treatments for viral diseases. He also currently serves on the board of Grove Bank & Trust and Morgan Solar. He has been a member of the Board of Trustees of the University of Miami since 1983 and was Chairman from 2001 to 2004. He is on the Advisory Board of the Shanghai Institute for Advanced Immunochemical Studies in China, is a member of The Florida Council of 100 and is a trustee of the Miami Jewish Home for the Aged and serves on the Executive Committee of the Board of Mount Sinai Medical Center. He serves as Chairman of Temple Emanu-El, Governor of Tel Aviv University and is a member of the Executive Committee of The Phillip and Patricia Frost Museum of Science. Dr. Frost served as a director of Ladenburg Thalmann Financial Services Inc. from 2004 to 2006 and as Chairman from July 2006 until September 2018. Dr. Frost previously served as a director for Castle Brands (NYSE American:ROX). Dr. Frost had served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation ("IVAX") from 1987 until its acquisition by Teva in January 2006. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc. from 1972 until its acquisition by Schering Plough Corporation in 1986. Dr. Frost was a Governor of the American Stock Exchange from 1992 to 2008 and Co-Vice Chairman from 2001 until its merger with the New York Stock Exchange.
- Richard M. Krasno
-
Richard M. Krasno曾担任the William R. Kenan, Jr. Charitable Trust执行董事，并于1999年10月起担任William R. Kenan, Jr. Funds4个附属公司的总裁。加入the Trust之前，Krasno博士是加利福尼亚蒙特利the Monterey Institute of International Studies公司总裁。Krasno博士还担任北卡罗莱纳大学医疗保健系统（the University of North Carolina Health Care System））董事会主席。从1981年到1998年他担任纽约的国际教育研究所（the Institute of International Education）总裁兼首席执行官。从1979年到1980年他还担任在华盛顿特区教育部长副助理（Deputy Assistant Secretary of Education）。
Richard M. Krasno,has served on the Company's Board of Directors since February 2017. Dr. Krasno has been a private investor in companies for the past six years. Dr. Krasno also served as the executive director of the William R. Kenan, Jr. Charitable Trust (the "Trust") from 1999 to 2014, and from 1999 to 2010, as President of the four affiliated William R. Kenan, Jr. Funds. Prior to joining the Trust, Dr. Krasno was the President of the Monterey Institute of International Studies in Monterey, California. From 2004 to 2012, Dr. Krasno also served as a Director of the University of North Carolina Health Care System and served as chairman of its board of directors from 2009 to 2012. From 1981 to 1998, he served as President and Chief Executive Officer of the Institute of International Education in New York. He also served as Deputy Assistant Secretary of Education in Washington, D.C. from 1979 to 1980. Dr. Krasno currently serves as a director of BioCardia, Inc. (NASDAQ GS: BCDA). He previously served as a director of Ladenburg Thalmann (NYSE American:LTS) and Castle Brands, Inc. (NYSE American:ROX). Dr. Krasno holds a Bachelor of Science from the University of Illinois and a Ph.D. from Stanford University. - Richard M. Krasno曾担任the William R. Kenan, Jr. Charitable Trust执行董事，并于1999年10月起担任William R. Kenan, Jr. Funds4个附属公司的总裁。加入the Trust之前，Krasno博士是加利福尼亚蒙特利the Monterey Institute of International Studies公司总裁。Krasno博士还担任北卡罗莱纳大学医疗保健系统（the University of North Carolina Health Care System））董事会主席。从1981年到1998年他担任纽约的国际教育研究所（the Institute of International Education）总裁兼首席执行官。从1979年到1980年他还担任在华盛顿特区教育部长副助理（Deputy Assistant Secretary of Education）。
- Richard M. Krasno,has served on the Company's Board of Directors since February 2017. Dr. Krasno has been a private investor in companies for the past six years. Dr. Krasno also served as the executive director of the William R. Kenan, Jr. Charitable Trust (the "Trust") from 1999 to 2014, and from 1999 to 2010, as President of the four affiliated William R. Kenan, Jr. Funds. Prior to joining the Trust, Dr. Krasno was the President of the Monterey Institute of International Studies in Monterey, California. From 2004 to 2012, Dr. Krasno also served as a Director of the University of North Carolina Health Care System and served as chairman of its board of directors from 2009 to 2012. From 1981 to 1998, he served as President and Chief Executive Officer of the Institute of International Education in New York. He also served as Deputy Assistant Secretary of Education in Washington, D.C. from 1979 to 1980. Dr. Krasno currently serves as a director of BioCardia, Inc. (NASDAQ GS: BCDA). He previously served as a director of Ladenburg Thalmann (NYSE American:LTS) and Castle Brands, Inc. (NYSE American:ROX). Dr. Krasno holds a Bachelor of Science from the University of Illinois and a Ph.D. from Stanford University.
- Richard J. Lampen
-
Richard J. Lampen于2021年1月14日被任命为矢量集团有限公司首席运营官，自1995年起担任矢量集团有限公司执行副总裁。1995年10月至2005年12月，Richard J.Lampen担任新谷公司执行副总裁兼总法律顾问，同时担任该公司董事。Richard J. Lampen还担任Douglas Elliman的执行副总裁兼首席运营官以及董事会成员。从2006年9月至2020年2月，他担任Ladenburg Thalmann金融服务公司总裁兼首席执行官以及董事。Richard J. Lampen还于2018年9月至2020年2月担任Ladenburg Thalmann金融服务公司董事长。2008年10月至2019年10月，Richard J. Lampen担任Castle Brands股份有限公司总裁兼首席执行官以及董事。
Richard J. Lampen,has served as a member of Company's Board since December 2021 and serves as Douglas Elliman Inc. Executive Vice President and Chief Operating Officer. He also serves a member of the Board of Managers of Douglas Elliman Inc. subsidiary, Douglas Elliman Realty, LLC. Mr. Lampen has served as Executive Vice President of Vector Group (NYSE: VGR) since 1995 and was appointed Chief Operating Officer and was elected to the Board of Directors of Vector Group in 2021. From September 2006 to February 2020, he served as President and CEO as well as a director of Ladenburg Thalmann Financial Services ("LTS") prior to its acquisition by Advisor Group, a portfolio company of Reverence Capital Partners. Mr. Lampen also served as Chairman of LTS from September 2018 to February 2020. nds Inc. and as a director of other publicly traded corporations. - Richard J. Lampen于2021年1月14日被任命为矢量集团有限公司首席运营官，自1995年起担任矢量集团有限公司执行副总裁。1995年10月至2005年12月，Richard J.Lampen担任新谷公司执行副总裁兼总法律顾问，同时担任该公司董事。Richard J. Lampen还担任Douglas Elliman的执行副总裁兼首席运营官以及董事会成员。从2006年9月至2020年2月，他担任Ladenburg Thalmann金融服务公司总裁兼首席执行官以及董事。Richard J. Lampen还于2018年9月至2020年2月担任Ladenburg Thalmann金融服务公司董事长。2008年10月至2019年10月，Richard J. Lampen担任Castle Brands股份有限公司总裁兼首席执行官以及董事。
- Richard J. Lampen,has served as a member of Company's Board since December 2021 and serves as Douglas Elliman Inc. Executive Vice President and Chief Operating Officer. He also serves a member of the Board of Managers of Douglas Elliman Inc. subsidiary, Douglas Elliman Realty, LLC. Mr. Lampen has served as Executive Vice President of Vector Group (NYSE: VGR) since 1995 and was appointed Chief Operating Officer and was elected to the Board of Directors of Vector Group in 2021. From September 2006 to February 2020, he served as President and CEO as well as a director of Ladenburg Thalmann Financial Services ("LTS") prior to its acquisition by Advisor Group, a portfolio company of Reverence Capital Partners. Mr. Lampen also served as Chairman of LTS from September 2018 to February 2020. nds Inc. and as a director of other publicly traded corporations.
- Mark Zeitchick
-
Mark Zeitchick， 2006年9月以来一直是我们的执行副总裁。从1999年8月到2003年12月Zeitchick先生担任执行副总裁，从2006年9月到2011年12月Zeitchick先生担任Ladenburg Thalmann & Co. Inc.总裁兼首席执行官。他2001年3月是Ladenburg Thalmann & Co. Inc.的注册代表。2001年11月，Zeitchick先生担任Ladenburg Capital Management联合主席。从1995年9月到2001年11月，他担任Ladenburg Capital Management执行副总裁。从2001年5月到2001年11月，他担任Ladenburg Capital Management主席，2001年11月担任联合主席。2014年3月以来Zeitchick先生担任Castle Brands董事。
Mark Zeitchick has served as a director of our company since March 2014. Mr. Zeitchick has been executive vice president of Ladenburg Thalmann Financial Services Inc. since September 2006 and has served as a director of Ladenburg Thalmann Financial Services Inc. since 1999. From August 1999 until December 2003 Mr. Zeitchick served as an executive vice president of Ladenburg Thalmann Financial Services Inc. and from September 2006 until December 2011 Mr. Zeitchick served as president and chief executive officer of its subsidiary Ladenburg Thalmann & Co. Inc. Mr. Zeitchick has been a registered representative with Ladenburg Thalmann & Co. Inc. since March 2001. - Mark Zeitchick， 2006年9月以来一直是我们的执行副总裁。从1999年8月到2003年12月Zeitchick先生担任执行副总裁，从2006年9月到2011年12月Zeitchick先生担任Ladenburg Thalmann & Co. Inc.总裁兼首席执行官。他2001年3月是Ladenburg Thalmann & Co. Inc.的注册代表。2001年11月，Zeitchick先生担任Ladenburg Capital Management联合主席。从1995年9月到2001年11月，他担任Ladenburg Capital Management执行副总裁。从2001年5月到2001年11月，他担任Ladenburg Capital Management主席，2001年11月担任联合主席。2014年3月以来Zeitchick先生担任Castle Brands董事。
- Mark Zeitchick has served as a director of our company since March 2014. Mr. Zeitchick has been executive vice president of Ladenburg Thalmann Financial Services Inc. since September 2006 and has served as a director of Ladenburg Thalmann Financial Services Inc. since 1999. From August 1999 until December 2003 Mr. Zeitchick served as an executive vice president of Ladenburg Thalmann Financial Services Inc. and from September 2006 until December 2011 Mr. Zeitchick served as president and chief executive officer of its subsidiary Ladenburg Thalmann & Co. Inc. Mr. Zeitchick has been a registered representative with Ladenburg Thalmann & Co. Inc. since March 2001.
- John F. Beaudette
-
John F. Beaudette，他是我们公司的董事（2004年1月以来）。1995年以来，他担任MHW Ltd.（位于纽约曼哈塞特的国家酒饮料的进口、分销和服务的公司）的总裁兼首席执行官。MHW在全世界范围内提供酒厂、啤酒厂和酿酒厂的美国进口和分销服务。从1985年到1994年，他在PepsiCo Inc.和其附属公司Monsieur Henri Wines任职负责StolichnayaTM伏特加和其他红酒和烈酒品牌的分销。在这段时间，他担任PepsiCo Wines & Spirits Intl。的董事负责规划和Monsieur Henri Wines Ltd.的副总裁负责财务以及首席财务官。在加入百事可乐公司（PepsiCo）之前，他是Somerset Importers Ltd.、U.S. importers of TanquerayTM、Johnnie WalkerTM和其他烈酒品牌的会计经理。他目前在华盛顿特区的The National Association of Beverage Importers Inc.（NABI）担任董事、副主席以及财务委员会的主席。1983年加入饮料酒精行业的时候，他在the Penn Central Corporation执行全美各个行业包括能源、科技和房地产的子公司财务和运营的评论。他的相关经验、任职资格、品质和技能包括行业专业知识，管理经验以及作为我们公司的董事他获得的知识和经验。
John F. Beaudette has served as a director of our company since January 2004. Since 1995 Mr. Beaudette has been president and chief executive officer of MHW, Ltd., a national beverage alcohol import, distribution and service company located in Manhasset, New York. MHW, Ltd. provides U.S. import and distribution services to wineries, breweries, and distilleries throughout the world. He serves as Vice Chairman of the board of directors of The National Association of Beverage Importers Inc. NABI. - John F. Beaudette，他是我们公司的董事（2004年1月以来）。1995年以来，他担任MHW Ltd.（位于纽约曼哈塞特的国家酒饮料的进口、分销和服务的公司）的总裁兼首席执行官。MHW在全世界范围内提供酒厂、啤酒厂和酿酒厂的美国进口和分销服务。从1985年到1994年，他在PepsiCo Inc.和其附属公司Monsieur Henri Wines任职负责StolichnayaTM伏特加和其他红酒和烈酒品牌的分销。在这段时间，他担任PepsiCo Wines & Spirits Intl。的董事负责规划和Monsieur Henri Wines Ltd.的副总裁负责财务以及首席财务官。在加入百事可乐公司（PepsiCo）之前，他是Somerset Importers Ltd.、U.S. importers of TanquerayTM、Johnnie WalkerTM和其他烈酒品牌的会计经理。他目前在华盛顿特区的The National Association of Beverage Importers Inc.（NABI）担任董事、副主席以及财务委员会的主席。1983年加入饮料酒精行业的时候，他在the Penn Central Corporation执行全美各个行业包括能源、科技和房地产的子公司财务和运营的评论。他的相关经验、任职资格、品质和技能包括行业专业知识，管理经验以及作为我们公司的董事他获得的知识和经验。
- John F. Beaudette has served as a director of our company since January 2004. Since 1995 Mr. Beaudette has been president and chief executive officer of MHW, Ltd., a national beverage alcohol import, distribution and service company located in Manhasset, New York. MHW, Ltd. provides U.S. import and distribution services to wineries, breweries, and distilleries throughout the world. He serves as Vice Chairman of the board of directors of The National Association of Beverage Importers Inc. NABI.
- Steven D. Rubin
-
Steven D. Rubin，自企业于2009年10月合并，他担任董事会成员。他担任Ideation 的秘书从2007年6月至2009年10月。他一直是OPKO健康公司执行副总裁自2007年5月起，是OPKO健康公司的董事自2007年2月起，是冰霜集团有限责任公司（一家私人投资公司）的一员。他目前担任OPKO健康公司（一家专业的医疗保健公司），非侵入监测系统公司（一家医疗器械公司），Neovasc公司（血管器械开发商），Kidville公司（经营高档的儿童的学习和游乐设施），老虎X医药公司（前身为卡尔医药公司，前身是一家医疗器械公司），和城堡的品牌公司（高档白酒的营销商）的董事会成员。他曾担任梦公司（一家垂直整合的运动许可和产品的公司）， Ideation，TransEnterix公司（原SafeStitch医药公司）-一家医疗设备公司和PROLOR Biotech公司（一个发展阶段的生物制药公司）的董事会成员，在与OPKO健康公司合并之前。他曾任IVAX公司的高级副总裁，总法律顾问兼秘书从2001年8月至2006年9月。
Steven D. Rubin,has served as Executive Vice President – Administration since May 2007 and as a director of the Company since February 2007. Mr. Rubin currently serves on the board of directors of Red Violet, Inc. (NASDAQ CM:RDVT), a software and services company, Cocrystal Pharma, Inc. (NASDAQ GM:COCP), a publicly traded biotechnology company developing new treatments for viral diseases, Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical stage biopharmaceutical company dedicated to treating patients suffering from rare and ultra-rare disease caused by premature termination codon nonsense mutations, and ChromaDex Corp. (NASDAQ CM:CDXC), a science-based, integrated nutraceutical company devoted to improving the way people age. Mr. Rubin previously served as a director of Neovasc, Inc. (NASDAQ CM:NVCN), a company that develops and markets medical specialty vascular devices, Non-Invasive Monitoring Systems, Inc. (OTC US:NIMU), a medical device company, VBI Vaccines, Inc. (NASDAQ CM:VBIV), a biopharmaceutical company developing next generation vaccines, Cogint, Inc. (NASDAQ GM:COGT), now known as Fluent, Inc. (NASDAQ:FLNT), an information solutions provider focused on the data-fusion market, prior to the spin-off of its data and analytics operations and assets into Red Violet, Inc., Kidville, Inc. (OTCBB:KVIL), which operated large, upscale facilities, catering to newborns through five-year-old children and their families, and Castle Brands, Inc. (NYSE American:ROX), a developer and marketer of premium brand spirits. - Steven D. Rubin，自企业于2009年10月合并，他担任董事会成员。他担任Ideation 的秘书从2007年6月至2009年10月。他一直是OPKO健康公司执行副总裁自2007年5月起，是OPKO健康公司的董事自2007年2月起，是冰霜集团有限责任公司（一家私人投资公司）的一员。他目前担任OPKO健康公司（一家专业的医疗保健公司），非侵入监测系统公司（一家医疗器械公司），Neovasc公司（血管器械开发商），Kidville公司（经营高档的儿童的学习和游乐设施），老虎X医药公司（前身为卡尔医药公司，前身是一家医疗器械公司），和城堡的品牌公司（高档白酒的营销商）的董事会成员。他曾担任梦公司（一家垂直整合的运动许可和产品的公司）， Ideation，TransEnterix公司（原SafeStitch医药公司）-一家医疗设备公司和PROLOR Biotech公司（一个发展阶段的生物制药公司）的董事会成员，在与OPKO健康公司合并之前。他曾任IVAX公司的高级副总裁，总法律顾问兼秘书从2001年8月至2006年9月。
- Steven D. Rubin,has served as Executive Vice President – Administration since May 2007 and as a director of the Company since February 2007. Mr. Rubin currently serves on the board of directors of Red Violet, Inc. (NASDAQ CM:RDVT), a software and services company, Cocrystal Pharma, Inc. (NASDAQ GM:COCP), a publicly traded biotechnology company developing new treatments for viral diseases, Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical stage biopharmaceutical company dedicated to treating patients suffering from rare and ultra-rare disease caused by premature termination codon nonsense mutations, and ChromaDex Corp. (NASDAQ CM:CDXC), a science-based, integrated nutraceutical company devoted to improving the way people age. Mr. Rubin previously served as a director of Neovasc, Inc. (NASDAQ CM:NVCN), a company that develops and markets medical specialty vascular devices, Non-Invasive Monitoring Systems, Inc. (OTC US:NIMU), a medical device company, VBI Vaccines, Inc. (NASDAQ CM:VBIV), a biopharmaceutical company developing next generation vaccines, Cogint, Inc. (NASDAQ GM:COGT), now known as Fluent, Inc. (NASDAQ:FLNT), an information solutions provider focused on the data-fusion market, prior to the spin-off of its data and analytics operations and assets into Red Violet, Inc., Kidville, Inc. (OTCBB:KVIL), which operated large, upscale facilities, catering to newborns through five-year-old children and their families, and Castle Brands, Inc. (NYSE American:ROX), a developer and marketer of premium brand spirits.
高管简历
中英对照 | 中文 | 英文- Richard J. Lampen
Richard J. Lampen于2021年1月14日被任命为矢量集团有限公司首席运营官，自1995年起担任矢量集团有限公司执行副总裁。1995年10月至2005年12月，Richard J.Lampen担任新谷公司执行副总裁兼总法律顾问，同时担任该公司董事。Richard J. Lampen还担任Douglas Elliman的执行副总裁兼首席运营官以及董事会成员。从2006年9月至2020年2月，他担任Ladenburg Thalmann金融服务公司总裁兼首席执行官以及董事。Richard J. Lampen还于2018年9月至2020年2月担任Ladenburg Thalmann金融服务公司董事长。2008年10月至2019年10月，Richard J. Lampen担任Castle Brands股份有限公司总裁兼首席执行官以及董事。
Richard J. Lampen,has served as a member of Company's Board since December 2021 and serves as Douglas Elliman Inc. Executive Vice President and Chief Operating Officer. He also serves a member of the Board of Managers of Douglas Elliman Inc. subsidiary, Douglas Elliman Realty, LLC. Mr. Lampen has served as Executive Vice President of Vector Group (NYSE: VGR) since 1995 and was appointed Chief Operating Officer and was elected to the Board of Directors of Vector Group in 2021. From September 2006 to February 2020, he served as President and CEO as well as a director of Ladenburg Thalmann Financial Services ("LTS") prior to its acquisition by Advisor Group, a portfolio company of Reverence Capital Partners. Mr. Lampen also served as Chairman of LTS from September 2018 to February 2020. nds Inc. and as a director of other publicly traded corporations.- Richard J. Lampen于2021年1月14日被任命为矢量集团有限公司首席运营官，自1995年起担任矢量集团有限公司执行副总裁。1995年10月至2005年12月，Richard J.Lampen担任新谷公司执行副总裁兼总法律顾问，同时担任该公司董事。Richard J. Lampen还担任Douglas Elliman的执行副总裁兼首席运营官以及董事会成员。从2006年9月至2020年2月，他担任Ladenburg Thalmann金融服务公司总裁兼首席执行官以及董事。Richard J. Lampen还于2018年9月至2020年2月担任Ladenburg Thalmann金融服务公司董事长。2008年10月至2019年10月，Richard J. Lampen担任Castle Brands股份有限公司总裁兼首席执行官以及董事。
- Richard J. Lampen,has served as a member of Company's Board since December 2021 and serves as Douglas Elliman Inc. Executive Vice President and Chief Operating Officer. He also serves a member of the Board of Managers of Douglas Elliman Inc. subsidiary, Douglas Elliman Realty, LLC. Mr. Lampen has served as Executive Vice President of Vector Group (NYSE: VGR) since 1995 and was appointed Chief Operating Officer and was elected to the Board of Directors of Vector Group in 2021. From September 2006 to February 2020, he served as President and CEO as well as a director of Ladenburg Thalmann Financial Services ("LTS") prior to its acquisition by Advisor Group, a portfolio company of Reverence Capital Partners. Mr. Lampen also served as Chairman of LTS from September 2018 to February 2020. nds Inc. and as a director of other publicly traded corporations.
- John S. Glover
John S. Glover，2008年2月加入我们以来，他担任我们的首席运营官。从2008年2月到2008年10月，他担任我们的高级副总裁负责市场营销。从2006年6月到2008年2月，他担任Remy Cointreau USA的高级副总裁负责商业管理。从2001年1月到2006年6月，他担任美国和法国的 Remy Cointreau的各种管理职务。从1999年1月到2001年1月，他曾是荷兰Bols Royal Distilleries的董事总经理兼首席营销官。
John S. Glover, our executive vice president and chief operating officer, joined us in February 2008. From February 2008 to October 2008 Mr. Glover served as our senior vice president - marketing, since October 2008 he has served as our chief operating officer and since March 2017 he has served as our executive vice president. From June 2006 to February 2008 Mr. Glover served as senior vice president - commercial management of Remy Cointreau USA. From January 2001 to June 2006 Mr. Glover served in various management positions at Remy Cointreau in the United States and France. From January 1999 to January 2001 he was a managing director and chief marketing officer for Bols Royal Distilleries in the Netherlands.- John S. Glover，2008年2月加入我们以来，他担任我们的首席运营官。从2008年2月到2008年10月，他担任我们的高级副总裁负责市场营销。从2006年6月到2008年2月，他担任Remy Cointreau USA的高级副总裁负责商业管理。从2001年1月到2006年6月，他担任美国和法国的 Remy Cointreau的各种管理职务。从1999年1月到2001年1月，他曾是荷兰Bols Royal Distilleries的董事总经理兼首席营销官。
- John S. Glover, our executive vice president and chief operating officer, joined us in February 2008. From February 2008 to October 2008 Mr. Glover served as our senior vice president - marketing, since October 2008 he has served as our chief operating officer and since March 2017 he has served as our executive vice president. From June 2006 to February 2008 Mr. Glover served as senior vice president - commercial management of Remy Cointreau USA. From January 2001 to June 2006 Mr. Glover served in various management positions at Remy Cointreau in the United States and France. From January 1999 to January 2001 he was a managing director and chief marketing officer for Bols Royal Distilleries in the Netherlands.
- T. Kelley Spillane
T. Kelley Spillane，，2000年4月加入我们，他担任我们的高级副总裁发展全球销售。从2000年4月到2003年12月，他担任Great Spirits Company的副总裁负责销售。2003年12月他曾被任命为执行副总裁负责美国销售。在加入我们之前，他在Carillon Importers Limited（ Grand Metropolitan PLC的一个部门）任职。他开发并推出了Absolut Vodka和Bombay Sapphire Gin。他担任控制状态和免税部门的助理经理。他被提拔为特别账户董事从事于国民经济核算销售扩张。
T. Kelley Spillane, our senior vice president - global sales, joined us in April 2000. From April 2000 to December 2003 Mr. Spillane served as vice president - sales of Great Spirits Company, and was appointed executive vice president - U.S. sales in December 2003. He has served as our senior vice president - global sales since June 2013. Prior to joining us, Mr. Spillane worked at Carillon Importers Limited, a division of Grand Metropolitan PLC. Carillon developed and launched Absolut Vodka and Bombay Sapphire Gin. At Carillon, Mr. Spillane served as assistant manager for its control states and duty free divisions and was promoted to director of special accounts, focusing on expanding sales in national accounts.- T. Kelley Spillane，，2000年4月加入我们，他担任我们的高级副总裁发展全球销售。从2000年4月到2003年12月，他担任Great Spirits Company的副总裁负责销售。2003年12月他曾被任命为执行副总裁负责美国销售。在加入我们之前，他在Carillon Importers Limited（ Grand Metropolitan PLC的一个部门）任职。他开发并推出了Absolut Vodka和Bombay Sapphire Gin。他担任控制状态和免税部门的助理经理。他被提拔为特别账户董事从事于国民经济核算销售扩张。
- T. Kelley Spillane, our senior vice president - global sales, joined us in April 2000. From April 2000 to December 2003 Mr. Spillane served as vice president - sales of Great Spirits Company, and was appointed executive vice president - U.S. sales in December 2003. He has served as our senior vice president - global sales since June 2013. Prior to joining us, Mr. Spillane worked at Carillon Importers Limited, a division of Grand Metropolitan PLC. Carillon developed and launched Absolut Vodka and Bombay Sapphire Gin. At Carillon, Mr. Spillane served as assistant manager for its control states and duty free divisions and was promoted to director of special accounts, focusing on expanding sales in national accounts.
- Alfred J. Small
Alfred J. Small，Castle Brands公司高级副总裁、首席财务官、财务主管兼秘书，2004年10月加入Castle Brands Inc.。Small先生自2007年11月起担任Castle Brands首席财务官兼财务主管，自2009年1月起担任Castle Brands秘书。此前，他于2007年3月至2007年11月担任Castle Brands副总裁兼财务总监，并自2006年10月起担任Castle Brands首席会计官。斯Small先生是一名注册会计师。
Alfred J. Small, Castle Brands Inc. senior vice president, chief financial officer, treasurer and secretary joined Castle Brands Inc. in October 2004. Mr. Small has served as Castle Brands Inc. chief financial officer and treasurer since November 2007 and as Castle Brands Inc. secretary since January 2009. He previously served as Castle Brands Inc. vice president-controller from March 2007 until November 2007 and has served as Castle Brands Inc. principal accounting officer since October 2006. Mr. Small is a certified public accountant.- Alfred J. Small，Castle Brands公司高级副总裁、首席财务官、财务主管兼秘书，2004年10月加入Castle Brands Inc.。Small先生自2007年11月起担任Castle Brands首席财务官兼财务主管，自2009年1月起担任Castle Brands秘书。此前，他于2007年3月至2007年11月担任Castle Brands副总裁兼财务总监，并自2006年10月起担任Castle Brands首席会计官。斯Small先生是一名注册会计师。
- Alfred J. Small, Castle Brands Inc. senior vice president, chief financial officer, treasurer and secretary joined Castle Brands Inc. in October 2004. Mr. Small has served as Castle Brands Inc. chief financial officer and treasurer since November 2007 and as Castle Brands Inc. secretary since January 2009. He previously served as Castle Brands Inc. vice president-controller from March 2007 until November 2007 and has served as Castle Brands Inc. principal accounting officer since October 2006. Mr. Small is a certified public accountant.
- Alejandra Pena
Alejandra Pena，，2010年9月加入我们，她担任我们的高级副总裁负责市场营销。在加入 Castle Brands之前，她最近担任Remy Cointreau USA的利口酒和烈酒市场营销副总裁负责 Cointreau Liqueur和Mount Gay Rum还有其他品牌的市场营销。在她事业早期，她曾在Banfi任职。她是Italian Estate Wines的市场营销董事。她的事业始于担任战略咨询顾问。她能说流利的英语，西班牙和意大利。
Alejandra Pena, our senior vice president - marketing, joined us in September 2011. Prior to joining our company, Ms. Peña most recently served as marketing vice president for liqueurs and spirits for Remy Cointreau USA, where she was responsible for the marketing of Cointreau Liqueur and Mount Gay Rum in addition to other brands. Earlier in her career, she was employed with Banfi and served as marketing director of Italian Estate Wines. Ms. Peña started her career as a strategic consultant and is fluent in English, Spanish and Italian.- Alejandra Pena，，2010年9月加入我们，她担任我们的高级副总裁负责市场营销。在加入 Castle Brands之前，她最近担任Remy Cointreau USA的利口酒和烈酒市场营销副总裁负责 Cointreau Liqueur和Mount Gay Rum还有其他品牌的市场营销。在她事业早期，她曾在Banfi任职。她是Italian Estate Wines的市场营销董事。她的事业始于担任战略咨询顾问。她能说流利的英语，西班牙和意大利。
- Alejandra Pena, our senior vice president - marketing, joined us in September 2011. Prior to joining our company, Ms. Peña most recently served as marketing vice president for liqueurs and spirits for Remy Cointreau USA, where she was responsible for the marketing of Cointreau Liqueur and Mount Gay Rum in addition to other brands. Earlier in her career, she was employed with Banfi and served as marketing director of Italian Estate Wines. Ms. Peña started her career as a strategic consultant and is fluent in English, Spanish and Italian.